Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0197 USD | -10.05% | +12.57% | -68.68% |
May. 24 | Roche, LumiraDx Deal Probed by U.K. Competition Watchdog | DJ |
May. 20 | U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx | DJ |
Financials (USD)
Sales 2021 | 421.43 | Sales 2022 | 254.48 | Capitalization | 286M |
---|---|---|---|---|---|
Net income 2021 | -101M | Net income 2022 | -448M | EV / Sales 2021 | 5,817,897 x |
Net Debt 2021 | 200M | Net Debt 2022 | 347M | EV / Sales 2022 | 2,487,758 x |
P/E ratio 2021 |
-14.4
x | P/E ratio 2022 |
-0.57
x | Employees | 1,210 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
Latest transcript on LumiraDx Limited
1 day | -10.05% | ||
1 week | +12.57% | ||
Current month | -14.35% | ||
1 month | +15.88% | ||
3 months | +121.35% | ||
6 months | -82.09% | ||
Current year | -68.68% |
Managers | Title | Age | Since |
---|---|---|---|
Ron Zwanziger
CEO | Chief Executive Officer | 70 | 13-12-31 |
Dave Scott
FOU | Founder | 67 | 13-12-31 |
Dorian LeBlanc
DFI | Director of Finance/CFO | 49 | 16-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dave Scott
FOU | Founder | 67 | 13-12-31 |
Ron Zwanziger
CEO | Chief Executive Officer | 70 | 13-12-31 |
Troyen Brennan
BRD | Director/Board Member | 69 | 16-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 0.0197 | -10.05% | 266,278 |
24-05-24 | 0.0219 | +36.87% | 608,994 |
24-05-23 | 0.016 | -21.38% | 190,817 |
24-05-22 | 0.0204 | +16.29% | 410,556 |
24-05-21 | 0.0175 | -3.85% | 1,009,758 |
Delayed Quote OTC Markets, May 28, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-68.68% | 7.86M | |
+7.87% | 223B | |
+11.83% | 195B | |
+18.87% | 144B | |
+30.03% | 111B | |
+2.32% | 65.19B | |
+14.15% | 53.02B | |
+2.68% | 50.28B | |
+6.60% | 44.15B | |
+1.85% | 36.45B |
- Stock Market
- Equities
- LMDXF Stock